Cuál es el precio por RegeneRx Biopharmaceuticals, Inc. (RGRX)

Precio por RegeneRx Biopharmaceuticals, Inc. (RGRX) es de$0.0007

Cuál es la capitalización de mercado por RegeneRx Biopharmaceuticals, Inc. (RGRX)

Capitalización de mercado por RegeneRx Biopharmaceuticals, Inc. (RGRX) es $1.05K

RegeneRx Biopharmaceuticals, Inc. (RGRX) Acciones en Circulación

RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the advancement of therapeutic peptides, with a primary emphasis on thymosin beta 4, engineered for the protection, repair, and regeneration of tissues and organs. The company's development pipeline includes RGN-259, a preservative-free ophthalmic solution designed to restore corneal tissues following injury, disease, or other pathologies; RGN-352, an injectable formulation under investigation for its potential in treating cardiovascular ailments, central and peripheral nervous system disorders, and various other medical conditions; and RGN-137, a topical gel aimed at accelerating the healing of skin wounds and minimizing scar tissue. Strategic alliances have been forged with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. Incorporated in 1982, the company initially operated as Alpha 1 Biomedicals, Inc., adopting the name RegeneRx Biopharmaceuticals, Inc. in 2000. Its operations are headquartered in Rockville, Maryland.

Año	Acciones en circulación	Cambiar
Not enough data for the provided dates.

Año

Acciones en circulación

Cambiar

Not enough data for the provided dates.

Empresa	Acciones en circulación	Diferencia	País
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	-	US
Argenx SE ARGX.US	62.19M	-	NL
Lonza Group AG LONN.SW	-	-	CH
UCB S.A. UCB.BR	0.00	-	BE
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR

Empresa

Acciones en circulación

Diferencia

País